Age-related macular degeneration (AMD) is the leading cause of visual impairment and blindness registration in the developed world (figure 1).1 A rapidly ageing population has raised the priority of reducing the risk for age-related eye diseases that impair sight and quality of life. As there are currently 9.7 million people aged 65 and older in the UK and by 2020 one in five UK citizens will be aged 65 or older,2 it is imperative that more AMD research is conducted and additional help is given to those with the condition.
Figure 1: Atrophic ‘dry’ age-related macular degeneration
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here